75 Over a median period of 5 years, IPE resulted in a numerically lower risk of CV events (CV death, non-fatal MI, non-fatal IS, unstable angina, and coronary revascularization) that did not reach statistical significance (HR 0.79; 0.62–1.00; P = 0.055).
← all excerpts
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024.
1
0.0550
0.0550